Suchergebnisse - "Davis, Hugh"

PubPharm (24)

11

Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate : an open-label, randomized study

enthalten in: Clinical therapeutics | 2012

von Zhuang, Y. | Xu, Z. | Frederick, B. | +7

12

Bounded outcome score modeling : application to treating psoriasis with ustekinumab

enthalten in: Journal of pharmacokinetics and pharmacodynamics | 2011

von Hu, C. | Yeilding, N. | Davis, H. | +1

13

Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study

enthalten in: British journal of clinical pharmacology | 2011

von Xu, Z. | Bouman-Thio, E. | Comisar, C. | +5

14

Population approach for exposure-response modeling of golimumab in patients with rheumatoid arthritis

enthalten in: Journal of clinical pharmacology | 2011

von Hu, C. | Xu, Z. | Zhang, Y. | +3

15

Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and Caucasian male subjects

enthalten in: Journal of clinical pharmacology | 2010

von Ling, J. | Lyn, S. | Xu, Z. | +9

16

Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects

enthalten in: Journal of clinical pharmacology | 2010

von Xu, Z. | Wang, Q. | Zhuang, Y. | +8

17

Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis

enthalten in: Journal of clinical pharmacology | 2010

von Zhou, H. | Hu, C. | Zhu, Y. | +4

18

Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Puchalski, T. | Prabhakar, U. | Jiao, Q. | +2

19

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis

enthalten in: European journal of clinical pharmacology | 2009

von Fasanmade, A. | Adedokun, O. | Ford, J. | +5

20

Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritis

enthalten in: Journal of clinical pharmacology | 2009

von Xu, Z. | Vu, T. | Lee, H. | +9